Bruker Corporation Investor Day 2023
INVESTOR DAY 2023
Bruker at a Glance
Leading provider of high-value life science tools and solutions
▪ #1 or #2 market position in majority of our portfolio
Deep expertise in physics, chemistry, and biology
Organic growth, innovation and high RolC philosophy
■
2022 BSI (2) Markets
Applied/Food
Semi-Metrology 4%
10%
Microbiology
10%
BioPharma 16%
Industrial & Green Tech
2023 Bruker
21%
Academic &
Government
39%
Bruker
Core
>$2.8B(¹)
Revenue
2022 Project Accelerate 2.0
PA
2.0
56%
10⁰
Project Accelerate 2.0 Drives
Revenue Growth & Margins
>8,500
Colleagues
TIMI
30%
Repositioned for Strong Secular Trends,
Diversified Markets Mitigate Risk
(1) 2023 guidance. (2) Bruker Scientific Instruments (BSI) revenue reflects sum of BSI BioSpin, BSI CALID and BSI Nano Segments
2022 BSI (2) by Geography
BRUKER
34%
R&D ~10%
of Revenue
36%
Balanced Mix, with Recent
Rapid Growth in US
Innovation with Integrity | June 15, 2023
1
6View entire presentation